Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T M Lock

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
The Journal of Urology|May 1, 1987
Metastatic cancer of the prostate managed with buserelin versus buserelin plus cyproterone acetateF H Schroeder, T M Lock, D R Chadha, et al.
Pediatrics|June 5, 2001
Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settingsW E Pelham, E M Gnagy, L Burrows-Maclean, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
The Journal of Urology|May 1, 1987
Metastatic cancer of the prostate managed with buserelin versus buserelin plus cyproterone acetateF H Schroeder, T M Lock, D R Chadha, et al.
Pediatrics|June 5, 2001
Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settingsW E Pelham, E M Gnagy, L Burrows-Maclean, et al.
Pageof 2